Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person UniProt:P36639-3 NUDT1
| Class:Id | ReferenceIsoform:217453 |
|---|---|
| _chainChangeLog | transit peptide:1-18 added on Fri February 6 2015;chain:19-197 added on Fri February 6 2015;transit peptide:1-18 for 217453 removed on Fri February 25 2022;chain:19-197 for 217453 removed on Fri February 25 2022;chain:1-156 for 217453 added on Fri February 25 2022 |
| _displayName | UniProt:P36639-3 NUDT1 |
| _timestamp | 2025-05-21 21:16:35 |
| chain | chain:1-156 |
| checksum | B9FB669FF0ACFF5F |
| comment | FUNCTION Oxidized purine nucleoside triphosphate hydrolase which is a prominent sanitizer of the oxidized nucleotide pool (PubMed:10608900, PubMed:12857738, PubMed:22556419, PubMed:24695224, PubMed:24695225, PubMed:26238318, PubMed:28679043, PubMed:7713500, PubMed:8226881). Catalyzes the hydrolysis of 2-oxo-dATP (2-hydroxy-dATP) into 2-oxo-dAMP (PubMed:10373420). Also has a significant hydrolase activity toward 2-oxo-ATP, 8-oxo-dGTP and 8-oxo-dATP (PubMed:10373420, PubMed:11139615). Through the hydrolysis of oxidized purine nucleoside triphosphates, prevents their incorporation into DNA and the subsequent transversions A:T to C:G and G:C to T:A (PubMed:10373420, PubMed:10608900, PubMed:11756418, PubMed:12857738, PubMed:16607562, PubMed:24695224, PubMed:24695225, PubMed:26999531, PubMed:28035004, PubMed:8226881). Also catalyzes the hydrolysis of methylated purine nucleoside triphosphate preventing their integration into DNA (PubMed:30304478, PubMed:32144205). Through this antimutagenic activity protects cells from oxidative stress (PubMed:10608900, PubMed:12857738, PubMed:24695224, PubMed:24695225, PubMed:30304478, PubMed:32144205, PubMed:7713500, PubMed:8226881).CATALYTIC ACTIVITY 2-oxo-dATP + H2O = 2-oxo-dAMP + diphosphate + H(+)CATALYTIC ACTIVITY 2-oxo-ATP + H2O = 2-oxo-AMP + diphosphate + H(+)CATALYTIC ACTIVITY 8-oxo-dGTP + H2O = 8-oxo-dGMP + diphosphate + H(+)CATALYTIC ACTIVITY 8-oxo-dATP + H2O = 8-oxo-dAMP + diphosphate + H(+)CATALYTIC ACTIVITY O(6)-methyl-dGTP + H2O = O(6)-methyl-dGMP + diphosphate + H(+)CATALYTIC ACTIVITY N(6)-methyl-dATP + H2O = N(6)-methyl-dAMP + diphosphate + H(+)CATALYTIC ACTIVITY N(6)-methyl-ATP + H2O = N(6)-methyl-AMP + diphosphate + H(+)COFACTOR Binds 2 Mg(2+) ion per subunit.ACTIVITY REGULATION Inhibited by 2-oxo-dADP and 8-oxo-dGDP.BIOPHYSICOCHEMICAL PROPERTIES kcat is 13.9 sec(-1) with 2-oxo-dATP as substrate (at 30 degrees Celsius and pH 8.0) (PubMed:10373420). kcat is 4.7 sec(-1) with 2-oxo-dATP as substrate (at 30 degrees Celsius and pH 7.2) (PubMed:10373420). kcat is 4.7 sec(-1) with 2-oxo-ATP as substrate (at 30 degrees Celsius and pH 8.0) (PubMed:11139615). kcat is 12.3 sec(-1) with 8-oxo-dGTP as substrate (at 30 degrees Celsius and pH 8.0) (PubMed:10373420). kcat is 2.1 sec(-1) with 8-oxo-dGTP as substrate (at 30 degrees Celsius and pH 7.2) (PubMed:10373420). kcat is 10.8 sec(-1) with 8-oxo-dATP as substrate (at 30 degrees Celsius and pH 8.0) (PubMed:10373420). kcat is 5.4 sec(-1) with O(6)-methyl-dGTP as substrate (at pH 7.5) (PubMed:32144205). kcat is 2.0 sec(-1) with N(6)-methyl-dATP as substrate (at pH 7.5) (PubMed:32144205). kcat is 8.2 sec(-1) with O(6)-methyl-dGTP as substrate (PubMed:30304478). kcat is 0.3 sec(-1) with O(6)-methyl-GTP as substrate (PubMed:30304478). Shows the best catalytic efficiency for the 2-oxo-dATP substrate (PubMed:10373420, PubMed:11139615). Shows a similar catalytic efficiency for 8-oxo-dGTP and O(6)-methyl-dGTP (PubMed:30304478).SUBUNIT Monomer.INTERACTION Mostly present in cytosol (PubMed:7782328). A minor proportion is mitochondrial (PubMed:7782328). A very small amount of the protein is associated with nuclei (PubMed:7782328).SUBCELLULAR LOCATION Widely expressed with highest expression in thymus, testis, embryo and proliferating blood lymphocytes.DEVELOPMENTAL STAGE In peripheral blood lymphocytes, expressed at much higher levels in proliferating cells than in resting cells.PTM The N-terminus is blocked.POLYMORPHISM A polymorphism between Met-1 and Met-19 removes a stop codon before the initiation codon for isoform p22 and gives rise to the production of isoform p26. The allele frequency of isoform p26 is about 20%.MISCELLANEOUS Contains a predicted transit peptide (1-18) for localization to the mitochondrion.MISCELLANEOUS Derived from a B-type mRNA with a polymorphic alteration (GU-->GC) at the beginning of exon 2c that converts an in-frame UGA to CGA yielding another in-frame AUG further upstream.SIMILARITY Belongs to the Nudix hydrolase family.CAUTION The role in cancer cell survival is under debate. Was originally considered to play a role as a sanitizing enzyme for oxidized nucleotide pools, and thus important for the survival of cancer cells (PubMed:24695224, PubMed:24695225). A later study indicates that NUDT1 plays a redundant role in eliminating oxidized nucleotides and that it is not essential for cancer cell proliferation and survival (PubMed:28679043). |
| created | [InstanceEdit:217385] Schmidt, EE, 2008-03-27 06:23:53 |
| description | recommendedName: fullName evidence="31"Oxidized purine nucleoside triphosphate hydrolase ecNumber evidence="4 7 8 9 13 17 18"3.6.1.56 alternativeName: 2-hydroxy-dATP diphosphatase alternativeName: 7,8-dihydro-8-oxoguanine triphosphatase alternativeName: 8-oxo-dGTPase alternativeName: fullName evidence="36"Methylated purine nucleoside triphosphate hydrolase ecNumber evidence="23 24"3.6.1.- alternativeName: Nucleoside diphosphate-linked moiety X motif 1 shortName: Nudix motif 1 |
| geneName | NUDT1 MTH1 |
| identifier | P36639 |
| isoformParent | |
| isSequenceChanged | FALSE |
| keyword | 3D-structure Alternative initiation Cytoplasm Direct protein sequencing Hydrolase Magnesium Metal-binding Mitochondrion Nucleus Proteomics identification Reference proteome RNA-binding Transit peptide |
| modified | [InstanceEdit:9836292] Weiser, Joel, 2023-05-25 [InstanceEdit:9852000] Weiser, Joel, 2023-11-03 [InstanceEdit:9917590] Weiser, Joel, 2024-08-09 [InstanceEdit:9926675] Weiser, Joel, 2024-11-03 [InstanceEdit:9939033] Weiser, Joel, 2025-02-21 [InstanceEdit:9948485] Weiser, Joel, 2025-05-21 |
| name | NUDT1 |
| referenceDatabase | [ReferenceDatabase:2] UniProt |
| referenceGene | [ReferenceDNASequence:9003951] ENSEMBL:ENSG00000106268 NUDT1 [Homo sapiens] |
| secondaryIdentifier | 8ODP_HUMAN A4D205 Q6LES7 Q6P0Y6 Q7Z7N6 Q8IV95 Q9UBM0 Q9UBM9 |
| sequenceLength | 156 |
| species | [Species:48887] Homo sapiens |
| variantIdentifier | P36639-3 |
| (referenceEntity) | [EntityWithAccessionedSequence:2395846] NUDT1 p21 [cytosol] [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by UniProt:P36639-3 NUDT1 (217453)
